RIOMET ER's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9962336 | SUN PHARM | Extended release suspension compositions |
May, 2035
(11 years from now) | |
Riomet Er is owned by Sun Pharm.
Riomet Er contains Metformin Hydrochloride.
Riomet Er has a total of 1 drug patent out of which 0 drug patents have expired.
Riomet Er was authorised for market use on 29 August, 2019.
Riomet Er is available in for suspension, extended release;oral dosage forms.
The generics of Riomet Er are possible to be released after 01 May, 2035.
Drugs and Companies using METFORMIN HYDROCHLORIDE ingredient
Market Authorisation Date: 29 August, 2019
Treatment: NA
Dosage: FOR SUSPENSION, EXTENDED RELEASE;ORAL
More Information on Dosage
RIOMET ER family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic